Cannlabs EBITDA Margin 2014-2015 | CANL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cannlabs (CANL) over the last 10 years. The current EBITDA margin for Cannlabs as of March 31, 2015 is .
| Cannlabs EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2015-03-31 | $0.00B | $0.00B | -400.00% |
| 2014-12-31 | $0.00B | $0.00B | -300.00% |
| 2014-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| CannLabs, Inc. provides solutions for intellectual property, cloud-based analytics and scientific methods to serve the cannabis industry. It provides cannabis testing services for potency, homogeneity, microbial contamination, aflatoxins, heavy metals, residual solvents, and pesticides. The company also offers data/analytics and consulting, as well as education services. It serves consumers, patients, growers, manufacturers, and distributors. CannLabs, Inc. is based in Denver, Colorado. | |||